Alkermes
ALKS
#2976
Rank
S$7.08 B
Marketcap
S$42.50
Share price
-0.98%
Change (1 day)
3.16%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): S$0.39 Billion

According to Alkermes's latest financial reports the company's current earnings are S$1.47 Billion. a decrease over its 2024 earnings that were of S$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 S$0.38 B-34.87%
2024 S$0.59 B-17.97%
2023 S$0.72 B-468.52%
2022 -S$0.2 Billion449.24%
2021 -S$35.77 Million-68.04%
2020 -S$0.12 Billion-52.1%
2019 -S$0.24 Billion64.49%
2018 -S$0.15 Billion-15.04%
2017 -S$0.17 Billion-34.2%
2016 -S$0.26 Billion-5.34%
2015 -S$0.27 Billion35084.97%
2014 -S$0.77 Million
2012 S$9.45 M-117.81%
2011 -S$53.08 Million-12.69%
2010 -S$60.79 Million94.3%
2009 -S$31.29 Million-117.7%
2008 S$0.17 B622.63%
2007 S$24.46 M
2004 -S$96.74 Million-14.48%
2003 -S$0.12 Billion11.88%
2002 -S$0.11 Billion39.65%
2001 -S$72.4 Million5.73%
2000 -S$68.48 Million-28.91%
1999 -S$96.32 Million237.28%
1998 -S$28.56 Million100.05%
1997 -S$14.28 Million-37.93%
1996 -S$23 Million82.72%
1995 -S$12.59 Million-26.79%
1994 -S$17.19 Million-72.78%
1993 -S$63.16 Million208.07%
1992 -S$20.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.72 B 10,946.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.82 B 5,283.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$12.97 B 3,255.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.80 B 2,434.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$11.87 B 2,971.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$17.96 B 4,544.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-S$0.27 Billion-169.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-S$0.35 Billion-189.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.74 B 608.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel